C07J 73/006
By sulfur as hetero atom
Official title: {by sulfur as hetero atom}
C07J73/006 (By sulfur as hetero atom) appears on 8 US grants and 5 published applications in this corpus.
Search patents in C07J- Granted patents
- 8
- Published applications
- 5
- Assignees
- 8
- Inventors
- 19
- Latest grant
- 23 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treating CNS disorders23 Sep 2025US 12,421,275 B2Sage Therapeutics, Inc.
- Compositions and methods for treating CNS disorders8 Aug 2023US 11,718,642 B2Sage Therapeutics, Inc.
- 11-aza, 11-thia and 11-oxa sterol compounds and compositions24 Sep 2013US 8,541,600 B2Harbor Therapeutics, Inc.
- 8-substituted B-nor-6-Thiaequilenin compounds having activity as selective estrogen receptor modulators17 Apr 2001US 6,218,425 B1Eli Lilly and Company
- 4-Oxa and 4-thia steroids7 Dec 1999US 5,998,464 AMerck & Co., Inc.
- Compositions and methods for treating cns disorders19 Mar 2026US 2026/0078143 A1Sage Therapeutics, Inc.
- Compositions and methods for treating cns disorders9 May 2024US 2024/0150393 A1Sage Therapeutics, Inc.
- Compositions and methods for treating cns disorders12 Nov 2020US 2020/0354399 A1Sage Therapeutics, Inc.
- 11-Aza, 11-Thia and 11-Oxa Sterol Compounds and Compositions16 Feb 2012US 2012/0041016 A1Harbor Therapeutics, Inc.
- Novel cyp17 inhibitors21 Jul 2011US 2011/0178065 A1Biomarin Pharmaceutical Inc.
Most cited
By later US patents
- Heterocyclic steroid compounds9US 5,219,879 AThe Du Pont Merck Pharmaceutical Company · 1993
- 4-Oxa and 4-thia steroids5US 5,998,464 AMerck & Co., Inc. · 1999
- Oxa- and thia-steroids4US 4,083,852 AShionogi & Co., Ltd. · 1978
- Compositions and methods for treating CNS disorders1US 11,718,642 B2Sage Therapeutics, Inc. · 2023